DR. DAVID PETER WOLFE MD NPI 1104825249

NPI Details

DR. David Peter Wolfe, MD is a rheumatology internal medicine in Chevy Chase, MD with 31 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. DR. David Peter Wolfe, MD NPI is 1104825249. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1995

The provider's business location address is:

5454 WISCONSIN AVE
SUITE 600
CHEVY CHASE, MD
ZIP 20815-901
Phone: (240) 497-0230
Fax: (240) 497-0233

The NPI 1104825249 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, tocilizumab, 1 mg (HCPCS:J3262)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
• Vitamin d-3 level (HCPCS:82306)
• X-ray of hand, minimum of 3 views (HCPCS:73130)
• X-ray of foot, minimum of 3 views (HCPCS:73630)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose (HCPCS:J7321)
• Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
• Uric acid level, blood (HCPCS:84550)
• Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes (HCPCS:97112)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Screening test for antibody to noninfectious agent (HCPCS:86255)
• Therapy procedure using manual technique, each 15 minutes (HCPCS:97140)
• Protein measurement, serum (HCPCS:84165)
• X-ray of knee, 3 views (HCPCS:73562)
• Rheumatoid factor level (HCPCS:86431)
• Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes (HCPCS:97110)
• Therapy procedure using functional activities (HCPCS:97530)
• Screening test for autoimmune disorder (HCPCS:86038)
• Calcium level, total (HCPCS:82310)
• Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care (HCPCS:G0283)
• X-ray of shoulder, minimum of 2 views (HCPCS:73030)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Aspiration and/or injection of fluid from medium joint (HCPCS:20605)
• Aspiration and/or injection of fluid from small joint (HCPCS:20600)
• Total protein level, blood (HCPCS:84155)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Fee covid-19 vac 14 res (HCPCS:0134A)

The enumeration date for this NPI number is 7/20/2005 and was last updated on 6/26/2012.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.